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Abstract
Background: Quality of life (QoL) of patients has become a central evaluation parameter that also
acts as an aid for decisions related to treatment strategies particularly for patients with chronic
illnesses. In Germany, one of the newer instruments attempting to measure distinct QoL aspects
is the "Herdecke Questionnaire for Quality of Life" (HLQ). In this study, we aimed to validate the
HLQ with respect to its factorial structure, and to develop a short form. The validation has been
carried out in relation to other questionnaires including the SF-36 Health Survey, the Mood-Scale
Bf-S, the Giessen Physical Complaints Questionnaire GBB-24 and McGill's Pain Perception Scale
SES.
Methods: Data for this study derived from a model project on the treatment of patients using
naturopathy methods in Blankenstein Hospital, Hattingen. In total, 2,461 patients between the ages
of 16 and 92 years (mean age: 58.0 ± 13.4 years) were included in this study. Most of the patients
(62%) suffered from rheumatic diseases. Factorial validation of the HLQ, it's reliability and external
consistency analysis and the development of a short form were carried out using the SPSS software.
Results:  Structural analysis of the HLQ-items pointed to a 6-factor model. The internal
consistency of both the long and the short version is excellent (Cronbach's α  is 0.935 for the HLQ-
L and 0.862 for the HLQ-S). The highest reliability in the HLQ-L was obtained for the "Initiative
Power and Interest" scale, the lowest for the 2-item scales "Digestive Well-Being" and the "Physical
Complaints". However, the scales found by factor analysis herein were only in part congruent with
the original 5-scale model which was approved a multitrait analysis approach. The new instrument
shows good correlations with several scales of other relevant QoL instruments. The scales
"Initiative Power and Interest", "Social Interaction", "Mental Balance", "Motility", "Physical
Complaints", "Digestive Well-Being" sufficiently differentiate the diagnostic groups, particularly
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between the patients suffering on connective tissue and soft tissue disorders from those with
metabolic and nutritional disorders or hypersensitivity reactions.
Conclusion: Both the factorial validation and the development of a consistent short-form of the
HLQ are important steps forward for researchers in the field of QoL who wish to use the HLQ as
a reliable and valid instrument. The results indicate that the HLQ is a unique QoL-instrument that
can be used for both in-patient and out-patient-treatment. However, to improve to profile of the
HLQ, there is still the need for strengthening the Questionnaire in the dimensions of physical well-
being. This is the subject of a separate ongoing study.
Background
The consideration of "quality of life" (QoL) in clinical
studies and various attempts to make this construct meas-
urable to determine therapeutic success is an ongoing
process. This is particularly the case in those therapeutic
attempts that focus on integrative aspects of disease man-
agement that in turn offer holistic care including a variety
of therapeutic directions. Here, the QoL has become a
central evaluation parameter. It simultaneously acts as an
aid for decisions on the choice of treatment strategy for
chronically ill patients [1], which is obviously a challeng-
ing therapeutic aim, and is at least as significant as
somatic parameters [2]. QoL has therefore become a lead-
ing criteria in many outcome studies alongside somatic
and economic factors. In the course of this development,
the concept of QoL is explicitly listed as outcome param-
eter in many medical societies' guidelines [3].
However, there are a variety of opinions regarding the fac-
tors that contribute to QoL. According to a WHO-defini-
tion, QoL relates to the physical, psychological and social
well-being of an individual as laid out by formal health
terms [4]. According to this definition, it is necessary to
differentiate between a general and a health related QoL
[5]. The former relates to aspects that exist independently
from any particular disease (e.g. items such as "being
spontaneous", or "feeling exhausted"), whereas the later
focuses on particular characteristics of specific diseases
(e.g. factors such as "walking distance" or "pain" in rheu-
matic diseases)
Despite the methodological difficulties involved in mak-
ing QoL measurable, we have seen the development of
numerous instruments for measuring disease specific
aspects of QoL [6-8] in the recent past. An advantage of
disease specific instruments is precise registration regard-
ing strains and limitations of specific diseases rather than
those of diseases in general. In addition, the course of clin-
ical diseases can be more easily registered because of the
development of disease-related questionnaires ("course of
disease sensitivity" of questionnaires). The majority of
current recommendations by health economists and clin-
ical pharmacological associations include suggestions
regarding the use of disease specific and general QoL ques-
tionnaires [9].
In Germany, one of the newer instruments attempting to
measure general QoL with a distinct focus is the
"Herdecke Questionnaire for Quality of Life" (HLQ is the
German acronym of the phrase "Herdecke Questionnaire
for Quality of Life") [10,11]. Clinical research projects
have been reluctant to employ the HLQ although it was
evaluated on a sample of healthy subjects, and that some
reference values of clinical studies on different diseases do
exist, and also despite of the fact that the HLQ has a very
comprehensive understanding of the QoL problematic
[12],. This is mainly because conclusive validation based
on a large sample is still missing. To improve this situa-
tion, this study aimed to show the characteristics of the
HLQ, to describe its external validation using other test
instruments, and to develop a short form of the
questionnaire.
Methods
Data for this study derive from a model project on the
treatment of patients using naturopathy methods in
Blankenstein Hospital, Hattingen. To investigate the ben-
efits and limits of naturopathic treatment in the field of
in-patient care, the Department of Naturopathy was estab-
lished as a model at the Blankenstein Hospital in Hattin-
gen and was scientifically evaluated by the Chair of Medical
Theory and Complementary Medicine of Witten/Herdecke
University. This evaluation began on July 1st 1999 and was
completed on March 31th 2003. It focused on the follow-
ing question: "How does a three-week in-patient treat-
ment with naturopathic methods affect the QoL of the
patients, regarding a pre-post-comparison and a follow-
up carried out after 6 months? Detailed information con-
cerning this model project and its' scientific evaluation
can be found in [13] and [14].
In total, 2,461 patients between 16 and 92 years (mean
age 58.0 ± 13.4 years) were included in this study. The
socio-demographic characteristics of the patients are
shown in Table 1.Health and Quality of Life Outcomes 2005, 3:40 http://www.hqlo.com/content/3/1/40
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Alongside the HLQ, other standardized questionnaires
were used. These included the MOS-SF-36 Health Survey
[15], Zerssen's Mood-Scale Bf-S [16], the Giessener Physi-
cal Complaints Questionnaire GBB-24 [17] and McGill's
Pain Perception Scale SES [18].
The HLQ as referred to in this study uses 39 five-point lik-
ert scales ranging from 0 to 4 (agreement/disagreement or
often/never). In contrast to the SF-36, the items are not
defined by situations related to daily life and household
situations (shopping, career situations, physical activity).
As a result, the HLQ is very suitable for registering QoL
particularly in monitoring the course of a disease or ther-
apeutic intervention [19]. As an evaluation scheme,
Schulte et al. [10] described 5 scales of the 39 item HLQ,
unfortunately without any confirmation by factor analysis
Table 1: Socio-demographic data of the patient population
male (n = 507) female (n = 1954) total (n = 2461)
age mean 58,6 57,9 58,0
standard deviation 13,4 13,4 13,4
range 17–92 16–92 16–92
n% n % n%
age group under 18 years 1 0.2 3 0.2 4 0.2
18–45 years 89 17.6 346 17.7 435 17.7
45–60 years 162 32.0 676 34.6 838 34.1
60–65 years 81 16.0 308 15.8 389 15.8
65 and older 172 33.9 619 31.7 791 32.1
no details available 2 0.4 2 0.1 4 0.2
diagnostic groups connective tissue and soft tissue disorders 267 52.7 1305 66.8 1572 63.9
chronic disorders of the respiratory system 35 6.9 60 3.1 95 3.9
metabolic and nutritional disorders 92 18.1 133 6.8 225 9.1
hypersensitivity reactions 8 1.6 46 2.4 54 2.2
other indications 85 16.8 364 18.6 449 18.2
no details available 20 3.9 46 2.4 66 2.7
marital status single 56 11.0 178 9.1 234 9.5
married 352 69.4 1055 54.0 1407 57.2
living separated 7 1.4 34 1.7 41 1.7
divorced 37 7.3 227 11.6 264 10.7
widowed 36 7.1 399 20.4 435 17.7
second marriage 12 2.4 28 1.4 40 1.6
no details available 7 1.4 33 1.7 40 1.6
education still at school 2 0.4 7 0.4 9 0.4
no final exam 15 3.0 33 1.7 48 2.0
special school exams 1 0.2 5 0.3 6 0.2
secondary school exams other than GCSE 338 66.7 1191 61.0 1529 62.1
GCSE ? 80 15.8 431 22.1 511 20,8
A levels 60 11.8 201 10.3 261 10.6
other 1 0.2 27 1.4 28 1.1
no details available 10 2.0 59 3.0 69 2.8
most recent profession worker 206 40.6 338 17.3 544 22.1
employee/civil servant 212 41.7 941 48.2 1153 46.9
self employed 42 8.3 94 4.8 136 5.5
not working 15 3.0 242 12.4 257 10.4
unclear 1 0.2 23 1.2 24 1.0
no details available 31 6.1 316 16.2 347 14.1
professional situation full-time professional 142 280 311 15.9 453 18.4
part-time professional 19 3.8 288 14.8 307 12.4
housewife/husband 12 2.4 484 24.8 496 20.2
in training 4 0.8 13 0.7 17 0.7
retired pre retired state 267 49.6 670 33.3 937 38.2
unemployed 46 9.1 115 5.9 161 6.6
no details available 17 3.4 73 3.7 90 3.7Health and Quality of Life Outcomes 2005, 3:40 http://www.hqlo.com/content/3/1/40
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of the following areas: Physical Well-being (4 items),
Vitality (9 items), Mental behavior (10 items), Presence of
Personality (9 items), Social Environment (7 items). All
scales are expressed in percentage values from 0 = lowest
to 100 = highest QoL.
The main question of this study relates to the re-examina-
tion of the HLQ by means of a factor and reliability anal-
ysis and the explorative evaluation of the factors. External
validation was performed by correlating the HLQ scales
with those of the external test instruments: MOS-SF-36
Health Survey [15], Zerssen's Mood-Scale Bf-S [16], the
Table 2: Descriptive statistics and reliability parameters of HLQ-Items
Item
No.
Item Mean SD Item-Diff. 
Index
loading Cronbach's α  r Item-total old 
Scale
Total Scale-wise
long short long short
Initiative Power & Interest 0.885
10* good ideas 2.26 0.94 0.57 0.747 0.933 0.852 0.875 0.54 0.49 3
07* reacted spontaneously 2.13 1.08 0.53 0.640 0.934 0.855 0.880 0.47 0.42 3
11* concerned 2.72 1.02 0.68 0.630 0.932 0.846 0.871 0.67 0.61 3
08* decisive 2.44 0.91 0.61 0.617 0.934 0.852 0.876 0.54 0.48 4
12 put plans into action 2.09 0.91 0.52 0.572 0.933 0.877 0.58 4
25 difficult to take the initiative 2.33 1.12 0.58 0.535 0.932 0.873 0.65 4
36 enhanced personally 2.02 1.11 0.51 0.531 0.934 0.881 0.47 4
34 adapt to other people and situations 2.79 0.81 0.70 0.530 0.934 0.878 0.50 3
33 asserted in the environment 2.48 0.96 0.62 0.519 0.933 0.876 0.55 4
17 felt secure 2.36 0.95 0.59 0.481 0.932 0.874 0.66 4
21 future was clear 2.21 1.14 0.55 0.455 0.933 0.879 0.56 4
06 sought contact to others 2.27 1.10 0.57 0.453 0.935 0.884 0.41 5
30 felt enterprising/energetic 2.01 1.05 0.50 0.431 0.932 0.876 0.66 3
Social Interaction 0.812
16* felt left out 2.79 1.07 0.70 0.697 0.933 0.850 0.775 0.57 0.52 5
27* felt over-directed 2.90 1.10 0.73 0.636 0.933 0.853 0.780 0.57 0.51 4
20* abandoned community life 2.51 1.12 0.63 0.631 0.932 0.847 0.766 0.66 0.59 5
18 family life was a burden 2.92 1.18 0.73 0.546 0.934 0.792 0.52 5
32 didn't feel comfortable in the company of 
others
2.31 1.10 0.58 0.532 0.934 0.808 0.46 5
28 convey feelings to other 2.63 0.92 0.66 0.496 0.933 0.788 0.57 5
05 anxious/fearful 2.42 1.20 0.61 0.461 0.933 0.797 0.56 3
Mental Balance 0.812
35* nervous / irascibly 1.99 1.06 0.50 0.640 0.934 0.858 0.803 0.47 0.40 3
26* well-balanced 2.01 0.97 0.50 0.600 0.932 0.850 0.770 0.67 0.61 3
19* exhausted 1.24 0.94 0.31 0.567 0.933 0.849 0.782 0.59 0.56 2
09 could recover myself 1.57 0.99 0.39 0.557 0.933 0.784 0.55 2
31 tired 1.38 0.92 0.35 0.554 0.933 0.784 0.57 2
39 I happy 2.10 0.90 0.53 0.499 0.932 0.781 0.69 3
04 sleep was refreshing 1.55 1.05 0.39 0.356 0.935 0.809 0.42 2
Motility 0.781
22* physically agile 1.95 1.02 0.49 0.789 0.935 0.854 0.708 0.40 0.43 1
24* movement was light 1.84 1.07 0.46 0.786 0.934 0.851 0.673 0.47 0.46 1
38* arms and legs felt heavy 1.36 1.07 0.34 0.668 0.935 0.855 0.571 0.39 0.42 1
37 powerful 1.47 0.95 0.37 0.509 0.933 0.482 0.56 2
Physical Complaints 0.692
02* suffered from physical pain 1.04 0.97 0.26 0.726 0.936 0.859 * 0.27 0.32 1
01* felt ill 1.09 0.91 0.27 0.705 0.935 0.853 * 0.42 0.44 2
Digestive Well-Being 0.621
03* good appetite 2.71 1.12 0.68 0.763 0.935 0.857 * 0.37 0.38 2
23* mealtimes were a burden 2.87 1.10 0.72 0.734 0.934 0.853 * 0.45 0.46 2
number of answered items ranged from 2,227 [min.] and 2,430 [max.]
* Short form ItemHealth and Quality of Life Outcomes 2005, 3:40 http://www.hqlo.com/content/3/1/40
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Giessener Physical Complaints Questionnaire GBB-24
[17] and McGill's Pain Perception Scale SES [18].
Factor analysis was performed using principal compo-
nents analysis with Varimax rotation on 35 of the 39
items. The items, #13 (avoided conflicts), #14 (behavior
of others was unclear to me), #15 (was glad) and #29
(reduced sexual activity) were omitted following the pos-
itive preliminary results on the reliability of the HLQ by
Kroez et al. [20]. To determine the internal consistency of
the questionnaire, reliability analysis was performed
using Cronbach's alpha. Both factor analysis and reliabil-
ity analysis were performed for the long and the short ver-
sion of the HLQ.
For the short form, only relevant items with a factorial
weight of >0.6 were selected. This method of selection was
originally suggested by Grimley [21] and has successfully
been applied elsewhere [22,23].. Coefficients of determi-
nation (R-square) of short and long form scales were cal-
culated to evaluate the proportion of variance of the
original HLQ which can be explained by the short form.
Evaluation of responsiveness of the HLQ over a course of
time was achieved by analyzing the change of HLQ-total
score from the time of admission to the time of discharge
by using a dependent t-test and calculation of Cohen's
effect size (ES). Cohen's guidelines were used to classify
the magnitude of effect sizes: 0.2 represents a small effect,
0.5 a moderate effect, and 0.8 a large effect.
The statistical data evaluation was performed using the
SPSS Version 10.0 program packet.
Table 3: Partial Correlation of HLQ-Scales with other instruments and with the HLQ-Scales (old adjusted for Gender and Age. 
Abbrev.: SF-36: PF-physical function, RP-role physical, BP-bodily pain, GH-general health, VT-vitality, SF-social function, RE-role 
emotional, MH-mental health, MCS-mental component summary, PCS-physical component summary; GBB: SE-severity of 
exhaustion, GS-gastric symptoms, LP-limb pain, and HS-heart symptoms;, Zerssen's Mood Scale Bf-S; SES: AFF-Affective Pain, SENS-










long short long short Long short long short long Short long short
SF-36 PF 0.200 0.130 0.219 0.188 0.233 0.173 0.551 0.580 0.432 * 0.167 *
RP 0.234 0.178 0.252 0.226 0.294 0.257 0.461 0.453 0.403 * 0.184 *
BP 0.182 0.147 0.213 0.198 0.301 0.242 0.449 0.466 0.688 * 0.183 *
GH 0.358 0.288 0.363 0.308 0.361 0.322 0.353 0.332 0.350 * 0.208 *
VT 0.562 0.470 0.532 0.479 0.668 0.582 0.541 0.478 0.408 * 0.353 *
SF 0.543 0.437 0.632 0.589 0.550 0.486 0.392 0.342 0.337 * 0.324 *
RE 0.452 0.380 0.497 0.418 0.428 0.423 0.264 0.215 0.259 * 0.243 *
MH 0.650 0.543 0.686 0.605 0.719 0.690 0.378 0.316 0.324 * 0.360 *
MCS 0.650 0.548 0.698 0.615 0.667 0.640 0.294 0.213 0.245 * 0.348 *
PCS 0.020 -0.012 0.022 0.025 0.087 0.024 0.489 0.530 0.497 * 0.089 *
GBB 24 SE 0.458 0.363 0.513 0.457 0.626 0.546 0.559 0.496 0.387 * 0.323 *
GS 0.216 0.189 0.266 0.227 7 0.303 0.247 0.205 0.166 0.238 * 0.356 *
LP 0.249 0.201 0.296 0.263 0.386 0.312 0.490 0.498 0.514 * 0.190 *
HS 0.305 0.249 0.360 0.285 0.372 0.342 0.282 0.252 0.248 * 0.309 *
Bf-S 0.655 0.564 0.652 0.599 0.630 0.581 0.409 0.362 0.312 * 0.339 *
SES AFF 0.289 0.231 0.314 0.277 0.371 0.325 0.374 0.372 0.506 * 0.183 *
SENS 0.181 0.143 0.228 0.215 0.254 0.209 0.288 0.299 0.417 * 0.147 *
HLQ-
OLD
PWB 0.357 0.270 0.335 0.333 0.489 0.412 0.929 0.958 0.638 * 0.259 *
VIT 0.577 0.502 0.590 0.523 0.840 0.681 0.611 0.517 0.560 * 0.661 *
MEB 0.894 0.822 0.772 0.702 0.797 0.770 0.471 0.401 0.278 * 0.412 *
PERS 0.926 0.779 0.760 0.734 0.628 0.584 0.404 0.354 0.226 * 0.342 *
SOC 0.748 0.697 0.923 0.860 0.600 0.573 0.358 0.346 0.248 * 0.346 *
* values of the long version are identical with short versionHealth and Quality of Life Outcomes 2005, 3:40 http://www.hqlo.com/content/3/1/40
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Results
The descriptive statistics of each item, the reliability
parameters and the difficulty index are given in Table 2.
Considering the high percentage of patients with chronic
rheumatic diseases, an item-difficulty index between 0.26
(Item: "I suffered from physical pain") and 0.73 (Items
"Family life was a burden" and "I felt over directed") can
be regarded as sufficient. This also holds for item-total
correlations with values between 0.27 and 0.69 (median:
0.55) for the original HLQ and between 0.32 and 0.61
(median: 0.46) for the short version (HLQ-S), These cor-
relations are considered to be optimal ranges for psycho-
logical test instruments.
The results of the structural analysis of the HLQ-items
yielded surprising results. The scales found by factor anal-
ysis (Table 2) were only partly congruent with the scalesin
the original publication [10]. Instead, we found a new and
stable 6-factor-model which fits better with the original
data than the original 5-scale model derived by Schulte et
al., which used a multitrait analysis approach (developed
by Hays et al. [24]). This is underlined by a Kaiser-Meyer-
Olkin measure of sampling adequacy of 0.957 and a
highly significant Bartlett test of sphericity (p < 0.001).
The cumulative variance explained by this model is
54.7%.
Correlation analysis (Table 3) of the earlier HLQ scale
with the new scale revealed significant correlations
between the scales "Social Environment (SOC)" and
"Social Interaction (SOCI)" (r = 0.923 for the HLQ-L and
r = 0.860 for the HLQ-S). Unfortunately, such clear corre-
lation between an old HLQ scale with the unique factor of
our current analysis was not found with the other scales.
However, "physical well-being (PWB)" of the old HLQ
correlated well with the new "motility (MOT)" scale
(HLQ-L r = 0.929 resp. HLQ-S r = 0.958), while the old
"vitality (VIT)" scale correlates with the "mental balance
scale (MB)" (HLQ-L r = 0.840 resp. HLQ-S r = 0.681). The
old scales "presence of personality (PERS)" and "mental
balance (MEB)" are represented well by the new scale "ini-
tiative power and interest (IPI)" (See Table 3).
The internal consistency of the instruments (HLQ-L and
HLQ-S), both for the total score (Cronbach's α  is 0.935 for
the HLQ-L and 0.862 for the HLQ-S) as well as for the
subscales of the HLQ-L (Cronbach's α  between 0.621 and
0.885) can be regarded as being excellent. The highest
alpha reliability in the HLQ-L was obtained for the
"Initiative Power and Interest" scale, the lowest for the 2-
item scales "Digestive Well-Being" (0.621) and "Physical
Complaints" (0.692).
The mean difference between the scales of the HLQ-S and
the HLQ-L for all patients is between 1.20 ("Initiative
Power and Interest ") and 2.24 points ("Social interac-
tion") on a percentage scale. The absolute differences are
clustered in groups and are given in Table 4. Although
there is a low overall mean difference, absolute differences
greater than 10 percent range between 17.9% ("Initiative
Power and Interest") and 26.8% ("Social interaction").
However, with correlation coefficients ranging from 0.899
to 0.964, the proportion of variance of the HLQ-L can be
explained by the short form ranges between 79% and
93% and thus can be regarded as an adequate proportion
for a short version.
The correlation of the HLQ with other test instruments is
shown in Table 5. There are acceptable correlations with
r> 0.5 between the mental-health associated scales from
the HLQ with those of the other instruments, for example,
the "mental health"-Scale of the SF-36. In detail, the scales
Table 4: Comparison of the HLQ-L and the HLQ-S.
Difference 
of means
Percentage of Patients with a mean difference D Correlation Explained 
Variance





Initiative Power and Interest 1.20 32.9% 33.6% 15.6% 15.8% 2.1% 0.899 81%
Social Interaction 2.24 25.9% 27.3% 20.1% 22.2% 4.6% 0.909 83%
Mental Balance 1.43 27.8% 28.3% 19.6% 20.4% 3.9% 0.888 79%
Motility 1.43 46.5% 29.7% 11.9% 11.1% 0.8% 0.964 93%
Physical Complaints * ***** * *
Digestive well-Being * ***** * *
* values of the long version are identical with short versionHealth and Quality of Life Outcomes 2005, 3:40 http://www.hqlo.com/content/3/1/40
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Table 5: HLQ-scales (Mean ± SD)) of patients separated into diagnostic-, age-and gender specific groups.











Connective tissue and 
soft tissue disorders
18–45 M 43 56.4 ± 15.2 67.4 ± 18.9 42.8 ± 17,2 42.0 ± 18.4 25.3 ± 15.8 73.3 ± 20.3
F1 6
7
54.0 ± 15.2 64.2 ± 19.4 36.8 ± 15.8 38.7 ± 19.0 25.6 ± 17.4 67.4 ± 22.4
45–60 M 10
0
60.7 ± 16.9 69.9 ± 18.8 46.4 ± 16.0 42.8 ± 17.9 25.9 ± 14.0 77.0 ± 19.5
F4 8
3
54.5 ± 15.1 60.2 ± 18.9 37.9 ± 15.1 37.0 ± 18.4 21.6 ± 16.9 67.6 ± 23.3
60–65 M 36 64.9 ± 16.0 73.1 ± 17.9 47.4 ± 19.4 41.3 ± 19.6 29.9 ± 17.7 79.9 ± 21.6
F2 0
8
61.0 ± 15.5 66.9 ± 18.0 41.9 ± 15.0 40.3 ± 17.9 23.7 ± 16.3 74.3 ± 19.8
> 65 M 86 60.7 ± 16.9 70.7 ± 18.6 48.0 ± 16.5 36.9 ± 20.9 20.1 ± 19.2 75.1 ± 23.8
F4 3
7
61.0 ± 16.2 69.2 ± 18.0 46.1 ± 16.8 38.3 ± 21.4 19.4 ± 17.6 70.0 ± 24.7
Chronic disorders of 
the respiratory system
18–45 M 5 60.4 ± 19.2 70.7 ± 14.6 46.4 ± 20.0 42.5 ± 24.6 27.5 ± 31.1 85.0 ± 22.4
F 12 50.2 ± 9.0 62.2 ± 23.2 34.8 ± 12.1 49.0 ± 17.6 35.4 ± 19.1 59.4 ± 30.7
45–60 M 2 58.7 ± 14.9 73.2 ± 12.6 58.9 ± 7.6 43.8 ± 8.9 37.5 ± 0.00 81.3 ± 26.5
F 14 61.9 ± 11.0 66.6 ± 14.4 37.9 ± 10.3 39.4 ± 18.7 27.9 ± 17.0 65.2 ± 18.5
60–65 M 6 76.6 ± 6.9 72.0 ± 6.5 47.6 ± 10.5 48.9 ± 28.1 25.0 ± 17.7 85.4 ± 12.3
F 12 55.1 ± 17.6 67.7 ± 16.4 37.9 ± 16.1 41.7 ± 16.7 31.8 ± 20.4 59.4 ± 35.0
> 65 M 22 57.0 ± 18.3 67.7 ± 20.1 45.9 ± 18.2 43.2 ± 23.1 29.4 ± 22.7 65.3 ± 27.0
F 22 56.0 ± 15.3 67.2 ± 18.8 42.9 ± 14.2 48.6 ± 22.4 31.8 ± 24.9 69.3 ± 21.4
Metabolic and 
nutritional disorders
18–45 M 15 54.4 ± 16.2 64.8 ± 20.9 48.1 ± 18.5 53.9 ± 18.4 56.7 ± 29.8 77.5 ± 19.0
F 24 58.1 ± 14.9 69.3 ± 21.8 40.7 ± 13.6 45.3 ± 20.5 42.4 ± 28.4 64.1 ± 25.4
45–60 M 25 55.9 ± 16.3 71.4 ± 18.3 45.8 ± 14.8 40.8 ± 16.4 43.0 ± 27.3 75.5 ± 21.5
F 40 59.4 ± 16.7 65.9 ± 18.4 44.1 ± 17.6 46.3 ± 20.4 39.1 ± 24.1 72.8 ± 24.0
60–65 M 20 70.9 ± 12.6 81.6 ± 13.0 56.7 ± 14.8 53.7 ± 18.4 38.1 ± 21.3 80.0 ± 15.9
F 16 67.9 ± 10.4 74.3 ± 15.2 54.2 ± 10.7 44.9 ± 21.8 39.1 ± 28.5 83.6 ± 15.6
> 65 M 32 66.2 ± 15.0 75.8 ± 14.8 53.0 ± 14.6 49.5 ± 22.3 41.8 ± 19.7 79.3 ± 19.5
F 53 62.1 ± 17.3 70.6 ± 16.6 50.9 ± 19.3 45.3 ± 23.2 30.9 ± 25.2 76.2 ± 20.3
Hypersensitivity and 
allergic reactions
18–45 M 4 59.1 ± 10.5 68.8 ± 14.7 53.6 ± 28.1 64.1 ± 16.4 28.1 ± 12.0 68.7 ± 26.0
F 16 63.3 ± 17.1 73.8 ± 17.8 38.3 ± 16.2 46.9 ± 20.9 45.3 ± 29.5 67.2 ± 26.6
45–60 M 2 55.8 ± 35.4 62.5 ± 42.9 51.8 ± 37.9 43.8 ± 44.2 25.0 ± 35.4 87.5 ± 17.7
F 15 58.1 ± 14.6 69.9 ± 16.2 42.3 ± 16.1 48.8 ± 17.9 37.5 ± 22.2 61.7 ± 25.6
60–65 M - - - - - - -
F 8 51.8 ± 18.1 62.1 ± 22.4 32.5 ± 11.1 52.3 ± 17.0 28.1 ± 16.0 62.5 ± 25.0
> 65 M - - - - - - -
F 6 71.3 ± 12.9 77.0 ± 7.1 55.2 ± 22.3 60.4 ± 21.2 22.9 ± 12.3 83.3 ± 18.8
other indications 18–45 M 18 47.6 ± 17.5 62.9 ± 15.6 40.7 ± 16.1 48.6 ± 18.4 35.4 ± 16.7 63.2 ± 23.3
F1 2
2
53.8 ± 17.0 60.1 ± 19.8 35.2 ± 16.3 46.6 ± 21.5 35.9 ± 24.0 59.8 ± 24.2
45–60 M 28 57.2 ± 16.8 64.3 ± 25.0 41.8 ± 16.1 40.6 ± 19.1 34.8 ± 19.1 67.4 ± 27.1
F1 1
1
53.3 ± 17.0 58.1 ± 18.4 35.1 ± 14.1 43.9 ± 19.5 31.3 ± 19.6 59.8 ± 25.1
60–65 M 15 55.3 ± 16.8 69.5 ± 14.1 44.8 ± 16.8 45.4 ± 18.8 40.8 ± 28.9 71.7 ± 21.9
F 50 53.4 ± 18.1 58.4 ± 17.3 40.4 ± 14.7 49.6 ± 19.0 31.5 ± 20.7 63.0 ± 26.5
> 65 M 23 65.8 ± 18.8 72.5 ± 16.7 52.8 ± 16.5 52.5 ± 24.6 34.2 ± 27.5 83.2 ± 19.4
F 78 59.0 ± 17.6 69.0 ± 18.9 47.8 ± 16.9 50.6 ± 21.8 30.2 ± 27.0 70.7 ± 26.6Health and Quality of Life Outcomes 2005, 3:40 http://www.hqlo.com/content/3/1/40
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"Initiative Power and Interest", "Social Interaction" and
"Mental Balance" of the HLQ correlate well with "mental
health" and the "mental component summary", "Social
Functionand "Vitality" of the SF-36 and Zerssens Bf-S
Mood-Scale. The "motility" scale of the HLQ correlates
with "physical function" and "vitality" of the SF-36, with
the "severity of exhaustion" of the Giessener Physical
Complaints Questionnaire GBB 24, and somewhat
weaker with the "role physical", "bodily pain" and "phys-
ical component summary" scales of SF-36 and "limp
pain" of the GBB 24. The "physical complaints" subscale
of the HLQ correlates well with "bodily pain" of the SF-36
and its "physical component summary" scale, and also
with the "affection pain" subscale of McGill's Pain Percep-
tion Scales SES. Among the SF-36 scales, the factor "gen-
eral health" is not represented by the HLQ scales. The
factors, "gastric symptoms" and the "heart symptoms"
from the GBB 24 scales and "sensory pain" from the SES
are not represented by the HLQ.
According to the diagnostic spectrum (Table 5), the values
of the scale "Motility (MOT)" and "Physical Complaints
(PHY)" show particularly low values in patients suffering
from rheumatic diseases. Also, in contrast with other
scales of the HLQ, these two appear to have little correla-
tion with age, which indicates a suitable discriminatory
power of the HLQ considering age and different types of
disease.
The results from the responsiveness analysis are presented
in Table 6. We found a high sensitivity of the HLQ-scales
to change within the treatment with particularly high sig-
nificant changes in the mean and calculated effect sizes
between 0.39 (Digestive Well Being) and 0.92 (Mental
Balance).
Discussion
The aim of our study was to confirm the structure and con-
sistency of the HLQ. Surprisingly, we found that the orig-
inal scales presented earlier [10] were not in accordance
with the results of this factor analysis. However, the scales
"IPI-Initiative Power and Interest", "SOCI – Social Interac-
tion", "MB – Mental Balance", "MOT – Motility", "PHY-
Physical Complaints", "DWB – Digestive Well-Being"
show a good reliability and sufficiently differentiate the
diagnostic groups, especially between those patients suf-
fering with connective tissue and soft tissue disorders
from those with metabolic and nutritional disorders or
hypersensitivity reactions.
Although the HLQ sub-scales "Initiative Power and Inter-
est", "Social Interaction" and "Mental Balance" of the
HLQ correlate well with the corresponding SF-36 scales
and with Zerssens Bf-S Mood-Scale, and thus indicate that
these qualities share several interconnections, our find-
ings also showed that the HLQ provides several aspects of
health such as "Appetite and Digestive Affections" which
are not well covered by existing QoL-measures. Neverthe-
less, with only two items, the subscale "digestive well-
being" has to be strengthened by additional items. This is
also true for the scale related to physical complaints and
pain. With correlation values of 0.11 (physical total scale
of the SF-36) and 0.29 (sensory pain SES), it is quite obvi-
ous that this scale is deficient and needs an upgrade in
respect to quality and number of items.
As, according to [25] internal consistency reliability is a
poor predictor of responsiveness, we measured the
responsiveness of the HLQ directly using Cohen's effect
size. Together with the highly significant results of the t-
test statistics and being aware of the methodological lim-
itations which are immanent in obtaining results on a
questionnaires responsiveness by means of effect sizes
[26], we can nevertheless conclude that the HLQ shows
sufficient responsiveness for the use in a clinical setting.
In our opinion, the HLQ is more sensitive to health
changes brought about by Complementary Therapies
including anthroposophic medicine or homeopathy. This
does not mean that the HLQ is only suitable for such ther-
Table 6: Responsiveness of HLQ-scales measured with Cohen's effect size.
Mean Difference [95% 
CI] (Admission-
Discharge)
t-value N Effect-Size ES
Initiative Power and 
Interest
8.1 [7.4; 8.7] 24.89 2064 0.55
Social Interaction 11.0 [10.3; 11.7] 30.18 2062 0.67
Mental Balance 15.8 [15.1; 16.5] 41.75 2066 0.92
Motility 11.4 [10.6; 12.3] 25.49 2050 0.57
Physical Complaints 21.7 [20.6; 22.8] 39.96 2022 0.89
Digestive well-Being 9.8 [8.7; 10.9] 17.78 2053 0.39Health and Quality of Life Outcomes 2005, 3:40 http://www.hqlo.com/content/3/1/40
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apies. Although, there is a trend to consider QoL-ques-
tionnaires being specific for special complementary
therapies such as mistletoe treatment in cancer patients
[27], we do not favor such labels, as this might result in an
inflation of "new" QoL-measures for each new therapeu-
tic situation [28].
QoL is a multidimensional construct composed of func-
tional, physical, emotional, social and spiritual well-being
[29,30] with, several interconnections between distinct
constructs of well-being. The HLQ scales "Social Interac-
tion", "Mental Balance", "Motility", and "Physical Com-
plaints" share similarities with the these constructs, but
highlights two further significant topics, i.e. "Initiative
Power and Interest" and "Digestive Well-Being". The
highly relevant topic of spirituality and illness is
addressed in another instrument developed by our group,
the SpREUK questionnaire, with its sub-scales "Search for
meaningful support", "Positive interpretation of disease",
"Trust in external guidance", "Support through spiritual-
ity/religiosity" [22,31,32].
Our evaluation indicates an adequate representation of
aspects like "mental well-being" and "depression" which
are essential in defining QoL, and shows special features
of the HLQ that highlights its' uniqueness in the group of
generic QoL-measures. Particularly in clinical studies in
which, because of feasibility or patient compliance the use
of huge psychometric test batteries is inappropriate, the
HLQ now serves as a economic test-instrument. To con-
clude, we can state that this study presents necessary foun-
dations and developments for existing and future studies
that wish to use the HLQ as a reliable and valid
instrument.
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